Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, De Freitas Lopes AC, Gaba F, Brentnall A, Duffy S, Cui B, Coelho De Soarez P, Husain Z, Hopper J, Sadique Z, Mukhopadhyay A, Yang L, Berkhof J, Legood R. Manchanda R, et al. Among authors: patel s. Cancers (Basel). 2020 Jul 17;12(7):1929. doi: 10.3390/cancers12071929. Cancers (Basel). 2020. PMID: 32708835 Free PMC article.
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ, Turnbull C, Ramus SJ, Gayther SA, Pharoah PDP, Menon U, Jacobs I, Legood R. Manchanda R, et al. Among authors: patel s. J Natl Cancer Inst. 2018 Jul 1;110(7):714-725. doi: 10.1093/jnci/djx265. J Natl Cancer Inst. 2018. PMID: 29361001
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J, Li S, Southey M, Duffy S, Cuzick J, Dos Santos Silva I, Miners A, Sadique Z, Yang L, Legood R, Manchanda R. Sun L, et al. Among authors: patel s. JAMA Oncol. 2019 Dec 1;5(12):1718-1730. doi: 10.1001/jamaoncol.2019.3323. JAMA Oncol. 2019. PMID: 31580391 Free PMC article.
Comparative Effectiveness of Adalimumab vs Tofacitinib in Patients With Rheumatoid Arthritis in Australia.
Deakin CT, De Stavola BL, Littlejohn G, Griffiths H, Ciciriello S, Youssef P, Mathers D, Bird P, Smith T, O'Sullivan C, Freeman T, Segelov D, Hoffman D, Seaman SR; OPAL Rheumatology Network. Deakin CT, et al. JAMA Netw Open. 2023 Jun 1;6(6):e2320851. doi: 10.1001/jamanetworkopen.2023.20851. JAMA Netw Open. 2023. PMID: 37382956 Free PMC article. Clinical Trial.
15,452 results
You have reached the last available page of results. Please see the User Guide for more information.